The ratio of eicosapentaenoic acid (EPA) to arachidonic acid may be a residual risk marker in stable coronary artery disease patients receiving treatment with statin following EPA therapy
30 August 2016 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker
Nihon University Hospital, Tokyo (Japan)
26 More presentations in this session
Access the full session
The Event
ESC Congress 2016
30 August 2016
08:30 CET
